Ποια είναι η τιμή για Almirall, S.A. (ALM)

Η τιμή για Almirall, S.A. (ALM) είναι $12.43

Ποια είναι η κεφαλαιοποίηση αγοράς για Almirall, S.A. (ALM)

Η κεφαλαιοποίηση αγοράς για Almirall, S.A. (ALM) είναι $2.71B

Almirall, S.A. (ALM) Τιμή και Κεφαλαιοποίηση Αγοράς

Almirall, S.A. is a biopharmaceutical firm dedicated to the discovery, development, production, and commercialization of treatments primarily focused on skin health. Operating globally, with a significant presence in Europe and the United States, its product line targets various dermatological ailments such as actinic keratosis, atopic dermatitis, androgenic alopecia, psoriasis, onychomycosis, oncodermatology, and acne, alongside rare skin conditions. Beyond its core dermatology focus, the company also offers solutions for cardiovascular, musculoskeletal, respiratory, and nervous system disorders, as well as products for digestive health, anti-infectives for systemic use, genitourinary conditions and sex hormones, immunostimulants, and systemic hormonal preparations. Its extensive portfolio includes a range of well-known medications, such as Ilumetri, Solaraze, Skilarence, and Klisyri, among others. Almirall fosters strategic partnerships with numerous entities to advance its pipeline, including research institutions like the University of Dundee and commercial partners such as Eli Lilly and Company. Founded in Barcelona, Spain, in 1943, the company adopted its current name, Almirall, S.A., in May 2009, having previously been known as Laboratorios Almirall, S.A.

Η τιμή για ALM	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$23,362.72 $2.71B	NVDA	$5.088T	+187,840.61%
$21,256.09 $2.71B	AAPL	$4.629T	+170,893.88%
$18,907.37 $2.71B	GOOG	$4.118T	+151,999.70%
$16,928.84 $2.71B	MSFT	$3.687T	+136,083.45%
$12,855.55 $2.71B	AMZN	$2.800T	+103,316.02%

Η τιμή για ALM

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$23,362.72 $2.71B